short telomere syndrome implications for mds and aml patients
Published 1 year ago • 147 plays • Length 55:36Download video MP4
Download video MP3
Similar videos
-
4:39
short telomere syndromes in clinical practice
-
57:27
the telomere syndromes: a paradigm for molecular medicine
-
4:33
promising phase 2 trial results for patients with myelodysplastic syndrome and aml
-
23:50
spectrum of telomere-related ild | mary armanios, md
-
46:47
understanding myelodysplastic syndromes (mds)
-
1:11
what are telomeres? | telomere animation
-
59:45
11-12-20 - the growing clinical and genetic spectrum of telomere biology disorders
-
6:03
survival data for patients younger than 60 with primary myleofibrosis
-
4:28
telomere biology disorders explained
-
58:08
telomerase and the consequences of telomere dysfunction
-
3:54
molecular abnormalities influence patients with myelodysplastic syndromes after transplant
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
0:20
pml is required for telomere stability in non-neoplastic human cells
-
17:09
impact of telomere length & mutations | christine kim garcia, md
-
0:45
are mutations in terc template sequence reflected in telomeric repeats?
-
1:02
myelofibrosis: unmet needs
-
3:50
imetelstat efficacy is independent of molecular subtypes in r/r lr-mds
-
16:04
small molecular immunomodulators -- ep. 22 of 32